DD209577A5 - Verfahren zur herstellung eines glykoverwandten antigens - Google Patents

Verfahren zur herstellung eines glykoverwandten antigens Download PDF

Info

Publication number
DD209577A5
DD209577A5 DD82241290A DD24129082A DD209577A5 DD 209577 A5 DD209577 A5 DD 209577A5 DD 82241290 A DD82241290 A DD 82241290A DD 24129082 A DD24129082 A DD 24129082A DD 209577 A5 DD209577 A5 DD 209577A5
Authority
DD
German Democratic Republic
Prior art keywords
gra
lectin
cells
cancer
item
Prior art date
Application number
DD82241290A
Other languages
German (de)
English (en)
Inventor
Masakazu Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DD209577A5 publication Critical patent/DD209577A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DD82241290A 1981-10-01 1982-06-30 Verfahren zur herstellung eines glykoverwandten antigens DD209577A5 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (1)

Publication Number Publication Date
DD209577A5 true DD209577A5 (de) 1984-05-16

Family

ID=27526479

Family Applications (2)

Application Number Title Priority Date Filing Date
DD82241290A DD209577A5 (de) 1981-10-01 1982-06-30 Verfahren zur herstellung eines glykoverwandten antigens
DD82261475A DD221917A5 (de) 1981-10-01 1982-06-30 Verfahren zur herstellung von krebszellen-cytotoxischen lymphocyten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD82261475A DD221917A5 (de) 1981-10-01 1982-06-30 Verfahren zur herstellung von krebszellen-cytotoxischen lymphocyten

Country Status (19)

Country Link
AR (1) AR230731A1 (OSRAM)
AT (2) AT382080B (OSRAM)
AU (1) AU554858B2 (OSRAM)
BE (1) BE893704A (OSRAM)
CA (1) CA1195269A (OSRAM)
CH (2) CH655660B (OSRAM)
DD (2) DD209577A5 (OSRAM)
DE (2) DE3249568A1 (OSRAM)
DK (1) DK292182A (OSRAM)
FI (1) FI77157C (OSRAM)
FR (1) FR2513882B1 (OSRAM)
IL (1) IL66270A (OSRAM)
IT (1) IT1189305B (OSRAM)
MX (1) MX7437E (OSRAM)
NL (1) NL8202638A (OSRAM)
NO (1) NO161601C (OSRAM)
NZ (1) NZ201112A (OSRAM)
PT (1) PT75148B (OSRAM)
SE (1) SE8204058L (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Also Published As

Publication number Publication date
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
IT8248724A0 (it) 1982-06-30
ATA354585A (de) 1989-08-15
NO822215L (no) 1983-04-05
NO161601C (no) 1989-09-06
IT1189305B (it) 1988-02-04
CA1195269A (en) 1985-10-15
AU554858B2 (en) 1986-09-04
AT390002B (de) 1990-03-12
FI77157B (fi) 1988-10-31
FR2513882A1 (fr) 1983-04-08
PT75148B (en) 1986-08-14
NO161601B (no) 1989-05-29
FI77157C (fi) 1989-02-10
SE8204058D0 (sv) 1982-06-30
DE3249568A1 (de) 1985-02-07
DE3249568C2 (OSRAM) 1987-10-01
SE8204058L (sv) 1983-04-02
FR2513882B1 (fr) 1986-04-04
IL66270A0 (en) 1982-11-30
CH655661B (OSRAM) 1986-05-15
CH655660B (OSRAM) 1986-05-15
MX7437E (es) 1988-11-14
NL8202638A (nl) 1983-05-02
FI822325L (fi) 1983-04-02
DE3236298A1 (de) 1984-03-15
IT8248724A1 (it) 1983-12-30
AR230731A1 (es) 1984-06-29
NZ201112A (en) 1986-10-08
DK292182A (da) 1983-04-02
AT382080B (de) 1987-01-12
IL66270A (en) 1986-03-31
DE3236298C2 (OSRAM) 1987-09-24
ATA363782A (de) 1986-06-15
DD221917A5 (de) 1985-05-08
PT75148A (en) 1982-07-01
FI822325A0 (fi) 1982-06-29

Similar Documents

Publication Publication Date Title
DE69125735T2 (de) Verfahren zur Aktivierung der zytolytischen Wirkung von Lymphozyten unter Verwendung von anti-CD28-Antikörper
DE3689071T2 (de) Immunheilbehandlung.
DE69329344T2 (de) Spezifische modulationen des immunsystems
DE68920656T2 (de) Verwendung vpn Adenosin-5'-phosphate in der Behandlung von Krebscachexia.
DE3227262A1 (de) Verfahren zur herstellung von target-zellen-lysis-faktor und dessen verwendung
DE3812605A1 (de) Immunregulative stoffe und stoffgemische zur aktiven beeinflussung des krankheitsverlaufes
US6051613A (en) Nitrogen monoxide production suppressor
DE69110060T2 (de) In der humantherapie nützliche substanzen peptidischer natur.
DE9321535U1 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper
GB2082066A (en) Neem bark extracts possessing antineoplastic activities
DE69116321T2 (de) Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält
GB2106935A (en) Cancer cell-combatting lymphocytes process, for the production thereof, and anticancer agents containing said lymphocytes
PT1289535E (pt) Entidades apoptóticas para utilização no tratamento de desordens neurodegenerativas e de outras desordens neurológicas
DE102011111631A1 (de) Verfahren zur Herstellung von Medikamenten zur Tumorbekämpfung
DE60022499T2 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
DE3638124A1 (de) Neue pharmazeutische verwendung von ebselen
DE69624586T2 (de) Peptidvakzine auf basis von fusionsproteinen mit onkogenanteil
DD209577A5 (de) Verfahren zur herstellung eines glykoverwandten antigens
DE69527640T2 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
AU593210B2 (en) Process for preparing glycosidic linkage related antigen
DE3885798T2 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen.
DE68910956T2 (de) Mit toxin modifizierter antikörper.
EP0019167B1 (de) Arzneipräparat zur Behandlung von Carcinomen und Verfahren zu dessen Herstellung
EP1059931A2 (de) Verwendung von cd137 zur förderung der proliferation peripherer monocyten
DE69433472T2 (de) Recognin-vakzine

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee